Bonus questions [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2019-01-17 18:25 (740 d 16:36 ago) – Posting: # 19782
Views: 2,117

Bonus questions:

5. The link above makes references to the PIC/S guidances, specifically the PI011-3 one which makes reference to GAMP.
GAMP, in turn, is pay per view, so...

5a: Does this mean GAMP principles are enforced for inspectors?
If yes:
5b: Does that imply sponsors need to observe principles from GAMP for clinical trial software?
If yes:
5c: When I was a regulator I thought any and all principles that regulators want sponsors or stakeholders to follow is and will be accessible free of charge. I thought this was one of the noble aspects associated with the term transparency which was in almost every other sentence in documents published by agencies. I don't have a reference for it, but I thought was a practice. Can EU regulators enforce principles that are not in the public domain, free of charge, and will they really do so?

6. On a scale from 0 to 100 how grumpy do I sound ? :-D

PS nobody: My colon is fine, thanks for asking. One should never underestimate the importance of proper intestinal health and a good flora. :cool::ok::wink:

Pass or fail!

Complete thread:

 Admin contact
21,316 posts in 4,446 threads, 1,489 registered users;
online 8 (0 registered, 8 guests [including 2 identified bots]).
Forum time: Wednesday 11:01 CET (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz